Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 16
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07044960 | A Phase 1 Study of KHN702 Tablets in Healthy Subjects | ||
| NCT06589817 | A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia | ||
| NCT06393803 | Phase 1 Study of KH607 Tablets | ||
| NCT07096791 | A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression | ||
| NCT06364501 | Phase 1 Trial of KH801 | ||
| NCT06534723 | Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney) | ||
| NCT05772104 | Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder | ||
| NCT05672121 | Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) | ||
| NCT03232710 | Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition | ||
| NCT05667194 | Phase 1 Trial of KH617 | ||
| NCT06458595 | Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) | ||
| NCT07277933 | Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects | ||
| NCT07138001 | Phase 2 Clinical Trial of KH617 | ||
| NCT07101120 | A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive Disorder | ||
| NCT06825858 | A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration | ||
| NCT05657301 | Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration |
